Status:

COMPLETED

First-In Man (FIM) Study MR-Linac

Lead Sponsor:

Nucletron Operations BV

Collaborating Sponsors:

Factory CRO for Medical Devices B.V.

Conditions:

Bone Metastases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to confirm the p...

Detailed Description

This is a single center prospective proof of concept study including accuracy and safety aspects according to R-IDEAL stage 1 criteria. Five (5) patients with bone metastases will be treated with pall...

Eligibility Criteria

Inclusion

  • In order to be eligible to participate in this study, a patient must meet all of the following criteria:
  • Painful bone metastases in the lumbar spine
  • Radiographic evidence of bone metastases
  • Histologic proof of malignancy (primary carcinoma)
  • Karnofsky Performance Score ≥ 50
  • Age ≥ 18 years
  • Able to provide written informed consent

Exclusion

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Prior radiation therapy within the region planned to be irradiated
  • Contraindication for MRI according to screening protocol radiology department UMCU (e.g. cardiac pacemakers, and defibrillators, artificial heart valves or cochlear implants, https://richtlijn.mijnumc.nl/Beeld/MRI/Paginas/MRI-Veiligheid-Contra-indicaties.aspx
  • Claustrophobia
  • Standard systemic anti-cancer therapy or radionuclide therapy within 48 hours before or after treatment.
  • Any other type of not standard systemic anti-cancer treatment, except for endocrine treatment.
  • Unstable spine requiring surgical stabilization
  • Neurological deficit due to bone metastasis

Key Trial Info

Start Date :

April 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 8 2017

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT03284619

Start Date

April 1 2017

End Date

September 8 2017

Last Update

March 29 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Centre Utrecht

Utrecht, Netherlands, 3584 CX